<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39264106</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-9679</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Analytical methods : advancing methods and applications</Title><ISOAbbreviation>Anal Methods</ISOAbbreviation></Journal><ArticleTitle>Detection of gluten peptides in human duodenal fluids with immuno-liquid chromatography-mass spectrometry.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1039/d4ay00852a</ELocationID><Abstract><AbstractText>Gluten proteins are storage proteins in wheat that exhibit a certain resistance to gastrointestinal digestion. To explore solutions to cope with accidental ingestion of gluten in individuals suffering from gluten-related disorders, it is essential to monitor the fate of gluten peptides in biological samples, <i>i.e.</i>, gastrointestinal juices, blood plasma or urine. In this work, we aimed at developing a mass spectrometry (MS)-based method for measuring gluten peptides in human duodenal fluids. Seven gluten peptides, including the well-documented 33-mer gluten peptide (LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF), were selected after a literature review and characterization of a gluten-containing product. Isotopically labelled peptides were used as references and a targeted liquid chromatography (LC) MS assay based on high resolution parallel reaction monitoring (PRM) was designed. Despite iterative and fine tuning of the LC-PRM-MS method, the low level of endogenous gluten peptides in human duodenal fluid samples precluded their direct detection. Thus, an initial immunoprecipitation (IP) step was included. Several antibodies were tested, and one proved reliable for the enrichment of the 33-mer gluten peptide as well as a few additional gluten peptides. Figures-of-merits of the immuno-LC-PRM-MS assay were assessed with a focus on quantification trueness and precision. We have developed an MS-based method for measuring the 33-mer gluten peptide in human duodenal fluids. Based on isotopic dilution, the method relies on the combination of IP and LC-PRM-MS analysis. Measurements were shown to be sensitive, quantitative, and reproducible.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dayon</LastName><ForeName>Loïc</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8499-270X</Identifier><AffiliationInfo><Affiliation>Nestlé Institute of Food Safety &amp; Analytical Sciences, Nestlé Research, Société des Produits Nestlé SA, EPFL Innovation Park, Bâtiment H, CH-1015 Lausanne, Switzerland. loic.dayon@rd.nestle.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Núñez Galindo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nestlé Institute of Food Safety &amp; Analytical Sciences, Nestlé Research, Société des Produits Nestlé SA, EPFL Innovation Park, Bâtiment H, CH-1015 Lausanne, Switzerland. loic.dayon@rd.nestle.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevalier</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aquarius</LastName><ForeName>Michèl</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, VieCuri Medical Center, Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otten</LastName><ForeName>Britt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Human Biology, NUTRIM, Institute of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Food Innovation and Health, Centre for Healthy Eating and Food Innovation (HEFI), Maastricht University, Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troost</LastName><ForeName>Freddy J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Human Biology, NUTRIM, Institute of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Food Innovation and Health, Centre for Healthy Eating and Food Innovation (HEFI), Maastricht University, Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Affolter</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1568-4516</Identifier><AffiliationInfo><Affiliation>Nestlé Institute of Food Safety &amp; Analytical Sciences, Nestlé Research, Société des Produits Nestlé SA, EPFL Innovation Park, Bâtiment H, CH-1015 Lausanne, Switzerland. loic.dayon@rd.nestle.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anal Methods</MedlineTA><NlmUniqueID>101519733</NlmUniqueID><ISSNLinking>1759-9660</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39264106</ArticleId><ArticleId IdType="doi">10.1039/d4ay00852a</ArticleId></ArticleIdList></PubmedData></PubmedArticle>